KOL PULSE›RASolute 302 Trial

Rasonque Launch — Day-One KOL Network

Aug 26–28, 2026: mentions & retweets in the first 48 hours of the first RAS-inhibitor launch in pancreatic cancer · node size = impressions · gold ring = verified US physician

View the RASolute 302 Trial Profile →

Filters stack (AND) — e.g. US Physicians + ASCO 2026. Click again to remove.

View

US Influence

Other

Curated List

US Physician

International MD

Amplifier (RT)

Mentioned

Media / Org

Mention

Retweet